Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thure Filskov Overvad

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|April 22, 2020
Female Sex as a Risk Modifier for Stroke Risk in Atrial Fibrillation: Using CHA2DS2-VASc versus CHA2DS2-VA for Stroke Risk Stratification in Atrial Fibrillation: A Note of CautionPeter Brønnum Nielsen, Thure Filskov Overvad
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Correspondence: Current opinion of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on StrokePeter Brønnum Nielsen, Tatjana S Potpara, Thure Filskov Overvad
Ugeskrift for Laeger|November 13, 2015
[In Process Citation]Thure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Heart, Lung & Circulation|September 18, 2018
Stroke Risk Stratification: CHAThure Filskov Overvad, Tatjana S Potpara, Peter Brønnum Nielsen
Journal of the American College of Cardiology|May 14, 2016
Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing EvidenceThure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Circulation|December 21, 2018
Response by Overvad et al to Letter Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA<sub>2</sub>DS<sub>2</sub>-VA Score Rather Than CHA<sub>2</sub>DS<sub>2</sub>-VASc?"Thure Filskov Overvad, Torben Bjerregaard Larsen, Peter Brønnum Nielsen
Journal of General Internal Medicine|May 6, 2015
Comparison of Atrial Fibrillation GuidelinesThure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Cardiology and Therapy|July 8, 2016
Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive ReviewRasmus Kapalu Broge Richelsen, Thure Filskov Overvad, Svend Eggert Jensen
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2016
Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc scoreThure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y H Lip
Thrombosis and Haemostasis|April 15, 2016
Left atrial size and risk of stroke in patients in sinus rhythm. A systematic reviewThure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|April 22, 2020
Female Sex as a Risk Modifier for Stroke Risk in Atrial Fibrillation: Using CHA2DS2-VASc versus CHA2DS2-VA for Stroke Risk Stratification in Atrial Fibrillation: A Note of CautionPeter Brønnum Nielsen, Thure Filskov Overvad
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Correspondence: Current opinion of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on StrokePeter Brønnum Nielsen, Tatjana S Potpara, Thure Filskov Overvad
Ugeskrift for Laeger|November 13, 2015
[In Process Citation]Thure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Heart, Lung & Circulation|September 18, 2018
Stroke Risk Stratification: CHAThure Filskov Overvad, Tatjana S Potpara, Peter Brønnum Nielsen
Journal of the American College of Cardiology|May 14, 2016
Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing EvidenceThure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Circulation|December 21, 2018
Response by Overvad et al to Letter Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA<sub>2</sub>DS<sub>2</sub>-VA Score Rather Than CHA<sub>2</sub>DS<sub>2</sub>-VASc?"Thure Filskov Overvad, Torben Bjerregaard Larsen, Peter Brønnum Nielsen
Journal of General Internal Medicine|May 6, 2015
Comparison of Atrial Fibrillation GuidelinesThure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Cardiology and Therapy|July 8, 2016
Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive ReviewRasmus Kapalu Broge Richelsen, Thure Filskov Overvad, Svend Eggert Jensen
European Heart Journal. Cardiovascular Pharmacotherapy|August 14, 2016
Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc scoreThure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y H Lip
Thrombosis and Haemostasis|April 15, 2016
Left atrial size and risk of stroke in patients in sinus rhythm. A systematic reviewThure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, et al.
Pageof 5